IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.

Autor: Song D; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Cismas S; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Crudden C; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan, 1117, Amsterdam, The Netherlands., Trocme E; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Ophthalmic Pathology and Oncology Service, St. Erik Eye Hospital, Stockholm, Sweden., Worrall C; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Suleymanova N; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Lin T; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Tianjin International Joint Research and Development Centre of Ophthalmology and Vision Science, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China., Zheng H; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Seregard S; Ophthalmic Pathology and Oncology Service, St. Erik Eye Hospital, Stockholm, Sweden.; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Girnita A; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Skin Cancer Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden., Girnita L; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. leonard.girnita@ki.se.; Ophthalmic Pathology and Oncology Service, St. Erik Eye Hospital, Stockholm, Sweden. leonard.girnita@ki.se.

Publikováno v: Oncogene [Oncogene] 2022 Jan; Vol. 41 (4), pp. 600-611. Date of Electronic Publication: 2021 Nov 17.

Incidence of Retinoblastoma Has Increased: Results from 40 European Countries

Autor: Stacey AW, Bowman R, Foster A, Kivelä TT, Munier FL, Cassoux N, Fabian ID, Al Harby L, Alarcón Portabella S, Alia DB, All-Eriksson C, Antonino R, Astbury NJ, Balaguer J, Balwierz W, Barranco H, Bascaran C, Beck Popovic M, Biewald EM, Bobrova N, Bornfeld N, Brichard BG, Blum S, Capra M, Castela G, Catala J, Chantada G, Chernodrinska VS, Cieslik K, Comsa C, Correa Llano MG, Csóka M, De Potter P, Desjardins L, Dragomir MD, Fernández-Teijeiro A, García Aldana D, Gregersen PA, Gomel N, Hadjistilianou T, Hederova S, Hummlen M, Husakova K, Ida R, Ilic VR, Jenkinson H, Kapelushnik N, Kardava T, Keren-Froim N, Kepak T, Khotenashvili Z, Klett A, Krivaitiene D, Latinovic S, Lumbroso L, Lysytsia L, Maka E, Martín Begue N, Midena E, Moll AC, Murgoi G, Naumenko L, Neroev V, Nikitovic M, Olechowski A, Papyan R, Parrozzani R, Parulekar MV, Pawinska-Wasikowska K, Peric S, Pochop P, Polyakov VG, Reddy MA, Ritter-Sovinz P, Saakyan S, Sagoo MS, San Román Pacheco S, Seregard S, Silva S, Sorochynska T, Stathopoulos C, Stirn Kranjc B, Svojgr K, Tamamyan G, Tandili A, Tateshi B, Tekavcic Pompe M, Urbak SF, Ushakova TL, Valeina S, van Hoefen Wijsard M, Veleva-Krasteva NV, Viksnins M, Wackernagel W, Wolley Dod C, Yarovaya VA, Yarovoy AA, Zhilyaeva K, Zondervan M, Global Retinoblastoma Study Group

Publikováno v: Ophthalmology
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3a8377b4f24030141d8cf6658ae9fa5b
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18896

Increasing demand for ophthalmic pathology: time trends in a laboratory with nationwide coverage.

Autor: Stålhammar G; St. Erik Eye Hospital, Stockholm, Sweden. gustav.stalhammar@ki.se.; Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden. gustav.stalhammar@ki.se., Lardner E; St. Erik Eye Hospital, Stockholm, Sweden., Georgsson M; St. Erik Eye Hospital, Stockholm, Sweden., Seregard S; St. Erik Eye Hospital, Stockholm, Sweden.; Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: BMC ophthalmology [BMC Ophthalmol] 2023 Mar 06; Vol. 23 (1), pp. 88. Date of Electronic Publication: 2023 Mar 06.

A prognostic classification system for uveal melanoma based on a combination of patient age and sex, the American Joint Committee on Cancer and the Cancer Genome Atlas models.

Autor: Gill VT; Department of Pathology, Västmanland Hospital Västerås, Västerås, Sweden.; Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden., Sabazade S; Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden., Herrspiegel C; Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden., Ewens KG; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Opalko A; St. Erik Eye Hospital, Stockholm, Sweden., Dan N; St. Erik Eye Hospital, Stockholm, Sweden., Christersdottir T; Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden., Berg Rendahl A; Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden., Shields CL; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Seregard S; Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden., Ganguly A; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Stålhammar G; Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden.

Publikováno v: Acta ophthalmologica [Acta Ophthalmol] 2023 Feb; Vol. 101 (1), pp. 34-48. Date of Electronic Publication: 2022 Jul 08.

Trends in Uveal Melanoma Presentation and Survival During Five Decades: A Nationwide Survey of 3898 Swedish Patients.

Autor: Gill V; Department of Pathology, Västmanland Hospital Västerås, Västerås, Sweden.; Division of Eye and Vision, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Herrspiegel C; Division of Eye and Vision, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden., Sabazade S; Division of Eye and Vision, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden., Fili M; St. Erik Eye Hospital, Stockholm, Sweden., Bergman L; St. Erik Eye Hospital, Stockholm, Sweden., Damato B; St. Erik Eye Hospital, Stockholm, Sweden.; Ocular Oncology Service, Moorfields Eye Hospital, London, United Kingdom.; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom., Seregard S; Division of Eye and Vision, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden., Stålhammar G; Division of Eye and Vision, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2022 Jun 02; Vol. 9, pp. 926034. Date of Electronic Publication: 2022 Jun 02 (Print Publication: 2022).